The introduction of Retatrutide ZPHC, at a strength of 120mg, is sparking considerable interest within the weight loss community. This novel dual GIP and GLP-1 target medication suggests to deliver significant improvements in fat shedding compared to current therapies. Preliminary clinical studies h